137 related articles for article (PubMed ID: 1720036)
1. Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product.
Kuriu A; Ikeda H; Kanakura Y; Griffin JD; Druker B; Yagura H; Kitayama H; Ishikawa J; Nishiura T; Kanayama Y
Blood; 1991 Dec; 78(11):2834-40. PubMed ID: 1720036
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
Ikeda H; Kanakura Y; Tamaki T; Kuriu A; Kitayama H; Ishikawa J; Kanayama Y; Yonezawa T; Tarui S; Griffin JD
Blood; 1991 Dec; 78(11):2962-8. PubMed ID: 1720040
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human interleukin-9 induces protein tyrosine phosphorylation and synergizes with steel factor to stimulate proliferation of the human factor-dependent cell line, M07e.
Miyazawa K; Hendrie PC; Kim YJ; Mantel C; Yang YC; Kwon BS; Broxmeyer HE
Blood; 1992 Oct; 80(7):1685-92. PubMed ID: 1382699
[TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts.
Smolich BD; Yuen HA; West KA; Giles FJ; Albitar M; Cherrington JM
Blood; 2001 Mar; 97(5):1413-21. PubMed ID: 11222388
[TBL] [Abstract][Full Text] [Related]
5. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
Miyazawa K; Williams DA; Gotoh A; Nishimaki J; Broxmeyer HE; Toyama K
Blood; 1995 Feb; 85(3):641-9. PubMed ID: 7530502
[TBL] [Abstract][Full Text] [Related]
6. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
7. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Wisniewski D; Strife A; Clarkson B
Leukemia; 1996 Sep; 10(9):1436-42. PubMed ID: 8751459
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
Miyazawa K; Hendrie PC; Mantel C; Wood K; Ashman LK; Broxmeyer HE
Exp Hematol; 1991 Dec; 19(11):1110-23. PubMed ID: 1721591
[TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Spiekermann K; Faber F; Voswinckel R; Hiddemann W
Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
[TBL] [Abstract][Full Text] [Related]
10. Stem cell factor-induced signal transduction in rat mast cells. Activation of phospholipase D but not phosphoinositide-specific phospholipase C in c-kit receptor stimulation.
Koike T; Hirai K; Morita Y; Nozawa Y
J Immunol; 1993 Jul; 151(1):359-66. PubMed ID: 7686941
[TBL] [Abstract][Full Text] [Related]
11. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells.
Alai M; Mui AL; Cutler RL; Bustelo XR; Barbacid M; Krystal G
J Biol Chem; 1992 Sep; 267(25):18021-5. PubMed ID: 1381360
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells.
Miyazawa K; Toyama K; Gotoh A; Hendrie PC; Mantel C; Broxmeyer HE
Blood; 1994 Jan; 83(1):137-45. PubMed ID: 7506076
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
[TBL] [Abstract][Full Text] [Related]
14. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis.
Blume-Jensen P; Claesson-Welsh L; Siegbahn A; Zsebo KM; Westermark B; Heldin CH
EMBO J; 1991 Dec; 10(13):4121-8. PubMed ID: 1721869
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
16. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells.
Kanakura Y; Ikeda H; Kitayama H; Sugahara H; Furitsu T
Leuk Lymphoma; 1993 May; 10(1-2):35-41. PubMed ID: 7690631
[TBL] [Abstract][Full Text] [Related]
17. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors.
Pietsch T; Kyas U; Steffens U; Yakisan E; Hadam MR; Ludwig WD; Zsebo K; Welte K
Blood; 1992 Sep; 80(5):1199-206. PubMed ID: 1381238
[TBL] [Abstract][Full Text] [Related]
18. Stat1 associates with c-kit and is activated in response to stem cell factor.
Deberry C; Mou S; Linnekin D
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):73-80. PubMed ID: 9355737
[TBL] [Abstract][Full Text] [Related]
19. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.
Tsujimura T; Furitsu T; Morimoto M; Isozaki K; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
Blood; 1994 May; 83(9):2619-26. PubMed ID: 7513208
[TBL] [Abstract][Full Text] [Related]
20. Human stem cell factor is a growth factor for myeloid leukemia cells.
Pietsch T; Kyas U; Drexler HG; Welte K
Recent Results Cancer Res; 1993; 131():329-38. PubMed ID: 7692572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
